Medscape |
Less Is More: Patients With Colon Cancer Get a Chemo Break
Medscape CHICAGO — Most patients with low-risk stage III colon cancer will likely have their oxaliplatin-based adjuvant chemotherapy regimen cut in half, based on findings of the largest prospective trial on the issue to date, reported here at the American ... Three months of chemotherapy may be sufficient for stage III colon cancer Patients With Low-Risk Colon Cancer Can Have Less Chemotherapy, Reducing Neuropathy Mayo researchers present shorter chemotherapy for low-risk stage 3 colon cancer |
from Health - Google News http://ift.tt/2qVa3I8
EmoticonEmoticon